Interventional Cath Lab
He works at the interventionalist's side through diagnostic angiography, PCI, and stent deployment — where a clean case is a quiet one.
At the table when the heart is failing — and back at the bench designing what comes next.
Most people who design cardiovascular devices have never held a patient's hand while the device was working. Most people at the bedside never take an idea to the patent office. Scott lives on both sides of that line.
He has spent more than eight years where cardiovascular medicine is least forgiving — the cath lab and the intensive care unit. He is the nurse beside the interventional cardiologist during coronary angiography and stent deployment, reading the waveform as it changes, managing the anticoagulation, watching for the arrhythmia before the monitor calls it. In the ICU he holds the line for the sickest hearts, on mechanical support and titrated drips. It is work measured in minutes and millimeters.
What makes him rare is what he does after the case. Scott is an independent medical-device inventor, with U.S. patent filings on record with the USPTO in interventional cardiology and intracoronary drug delivery. His inventions begin not with a whiteboard, but with a problem he has felt through his own hands.
He works at the interventionalist's side through diagnostic angiography, PCI, and stent deployment — where a clean case is a quiet one.
In the intensive care unit he holds the line for the body's most unstable patients, from the ventilator to the titrated drip.
When a heart can no longer carry itself, he manages the IABP and Impella that carry it instead.
He reads pressure and rhythm as a single language, catching the deterioration in the waveform before it becomes a crisis.
Scott holds U.S. patent filings with the USPTO in interventional cardiology and intracoronary drug delivery — the rare case of a device concept authored by the person who lives with the procedure's limits firsthand. Ideas pressure-tested against real anatomy, real timing, and real hands, long before they reach a prototype. He is open to licensing, collaborative development, and partnership.
New approaches to reaching and treating the coronary artery.
Patent-Pending · USPTO FilingDelivering therapy precisely where the disease lives.
Patent-Pending · USPTO FilingIf you develop cardiovascular devices or therapeutics, there is value in an inventor who has already been in the room. Reach out about licensing, development, or partnership — or simply to start the conversation.
Scott@ScottRMayer.com